Publications

Found 1 results
Filters: Author is F. Yin  [Clear All Filters]
2012
F. H. Bai, Wang, N. J., Wang, J., Yang, L., Zhang, F. M., Yin, F., Liang, J., Wu, K. C., and Fan, D. M., Screening and identification of peritoneal metastasis-related genes of gastric adenocarcinoma using a cDNA microarray, vol. 11, pp. 1682-1689, 2012.
Arboleda MJ, Lyons JF and Kabbinavar FF (2003). Overexpression of AKT2/protein kinase Bh leads to up-regulation of h1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res. 63: 196-206. PMid:12517798   Bai F, Liang J, Wang J, Shi Y, et al. (2007). Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer. J. Mol. Med. 85: 169-180. http://dx.doi.org/10.1007/s00109-006-0115-8 PMid:17043801   Brito M, Malta-Vacas J, Carmona B, Aires C, et al. (2005). Polyglycine expansions in eRF3/GSPT1 are associated with gastric cancer susceptibility. Carcinogenesis 26: 2046-2049. http://dx.doi.org/10.1093/carcin/bgi168 PMid:15987717   Cho YG, Nam SW, Kim TY, Kim YS, et al. (2003). Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 111: 539-545. http://dx.doi.org/10.1034/j.1600-0463.2003.1110502.x PMid:12887505   Choi MG, Sung CO, Noh JH, Kim KM, et al. (2010). Mucinous gastric cancer presents with more advanced tumor stage and weaker beta-catenin expression than nonmucinous cancer. Ann. Surg. Oncol. 17: 3053-3058. http://dx.doi.org/10.1245/s10434-010-1184-z PMid:20645013   Davidson B, Zhang Z, Kleinberg L, Li M, et al. (2006). Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma. Clin. Cancer Res. 12: 5944-5950. http://dx.doi.org/10.1158/1078-0432.CCR-06-1059 PMid:17062665   Hippo Y, Yashiro M, Ishii M, Taniguchi H, et al. (2001). Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res. 61: 889-895. PMid:11221876   Huerta S, Harris DM, Jazirehi A, Bonavida B, et al. (2003). Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int. J. Oncol. 22: 663-670. PMid:12579322   Jemal A, Murray T, Ward E, Samuels A, et al. (2005). Cancer statistics, 2005. CA Cancer J. Clin. 55: 10-30. http://dx.doi.org/10.3322/canjclin.55.1.10 PMid:15661684   Kang YH, Lee HS and Kim WH (2002). Promoter methylation and silencing of PTEN in gastric carcinoma. Lab. Invest. 82: 285-291. http://dx.doi.org/10.1038/labinvest.3780422 PMid:11896207   Lazăr D, Raica M, Sporea I, Tăban S, et al. (2006). Tumor angiogenesis in gastric cancer. Rom. J. Morphol. Embryol. 47: 5-13. PMid:16838051   Lee SS, Jeong HE, Liu KH, Ryu JY, et al. (2005). Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity. Pharmacogenet. Genomics 15: 105-113. http://dx.doi.org/10.1097/01213011-200502000-00006 PMid:15861034   Li DW, Wu Q, Peng ZH, Yang ZR, et al. (2007). Expression and significance of Notch1 and PTEN in gastric cancer. Ai Zheng 26: 1183-1187. PMid:17991315   Li J, Wu Y, Qian X and Sha B (2006). Crystal structure of yeast Sis1 peptide-binding fragment and Hsp70 Ssa1 C-terminal complex. Biochem. J. 398: 353-360. http://dx.doi.org/10.1042/BJ20060618 PMid:16737444 PMCid:1559466   Mori K, Aoyagi K, Ueda T, Danjoh I, et al. (2004). Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem. Biophys. Res. Commun. 313: 931-937. http://dx.doi.org/10.1016/j.bbrc.2003.12.025 PMid:14706632   Motoori M, Takemasa I, Doki Y, Saito S, et al. (2006). Prediction of peritoneal metastasis in advanced gastric cancer by gene expression profiling of the primary site. Eur. J. Cancer 42: 1897-1903. http://dx.doi.org/10.1016/j.ejca.2006.04.007 PMid:16831544   Ong CK, Ng CY, Leong C, Ng CP, et al. (2004). Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J. Biol. Chem. 279: 743-754. http://dx.doi.org/10.1074/jbc.M308668200 PMid:14570898   Retterspitz MF, Monig SP, Schreckenberg S, Schneider PM, et al. (2010). Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis. Anticancer Res. 30: 4635-4641. PMid:21115917   Schena M, Shalon D, Davis RW and Brown PO (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470. http://dx.doi.org/10.1126/science.270.5235.467 PMid:7569999   Schieren G, Rumberger B, Klein M, Kreutz C, et al. (2006). Gene profiling of polycystic kidneys. Nephrol. Dial. Transplant 21: 1816-1824. http://dx.doi.org/10.1093/ndt/gfl071 PMid:16520345   Shapira M, Ben-Izhak O, Bishara B, Futerman B, et al. (2004). Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Cancer 100: 1615-1621. http://dx.doi.org/10.1002/cncr.20172 PMid:15073847   Wang J, Wu K, Bai F, Zhai H, et al. (2006). Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer. Cancer Lett. 242: 20-27. http://dx.doi.org/10.1016/j.canlet.2005.10.030 PMid:16338068   Wang YY, Ye ZY, Zhao ZS, Tao HQ, et al. (2010). High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann. Surg. Oncol. 17: 89-97. http://dx.doi.org/10.1245/s10434-009-0722-z PMid:19820999   Yanagihara K, Takigahira M, Tanaka H, Komatsu T, et al. (2005). Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci. 96: 323-332. http://dx.doi.org/10.1111/j.1349-7006.2005.00054.x PMid:15958054   Yonemura Y, Endou Y, Kimura K, Fushida S, et al. (2000). Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin. Cancer Res. 6: 4234-4242. PMid:11106237   Yonemura Y, Endo Y, Obata T and Sasaki T (2007). Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites. Cancer Sci. 98: 11-18. http://dx.doi.org/10.1111/j.1349-7006.2006.00350.x PMid:17052255   Yoon CS, Hyung WJ, Lee JH, Chae YS, et al. (2008). Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma. Hepatogastroenterology 55: 1916-1920. PMid:19102422   Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, et al. (2006). Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer. Hepatogastroenterology 53: 964-967. PMid:17153464